[Federal Register Volume 77, Number 52 (Friday, March 16, 2012)]
[Notices]
[Page 15761]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-6466]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Office of the Assistant Secretary for Health, Statement of 
Organization, Functions, and Delegation of Authority

    Part A. Office of the Secretary, Statement of Organization, 
Functions, and Delegation of Authority for the U.S. Department of 
Health and Human Services is being amended at Chapter AC, Office of the 
Assistant Secretary for Health (OASH), as last amended at 60 FR 56605-
06, dated November 9, 1995; 60 FR 8410, dated February 14, 1995; and 
most recently at 75 FR 53304-05, dated August 31, 2010, as follows:
    1. Under Chapter AC, delete Paragraph H, ``Office of HIV/AIDS 
Policy (ACJ)'', in its entirety and replace with the following:

    H. Office of HIV/AIDS and Infectious Disease Policy (ACJ)

    The Office of HIV/AIDS and Infectious Disease Policy (OHAIDP) is 
under the direction of the Deputy Assistant Secretary for Health, 
Infectious Diseases, who serves as the Director of the Office of HIV/
AIDS and Infectious Disease Policy, and as the principal advisor to the 
Assistant Secretary for Health (ASH) and the Secretary on health policy 
and program issues related to HIV disease and infectious diseases of 
public health significance. These issues cut across Health and Human 
Services (HHS) components which provide research, services, prevention, 
treatment, and education and information dissemination to susceptible 
populations.
    OHAIDP is responsible for coordinating, integrating, and directing 
the Department's policies, programs, and activities related to HIV/
AIDS, viral hepatitis, other infectious diseases of public health 
significance, and blood safety and availability. The Office: (1) 
Facilitates and/or coordinates policy planning processes related to 
infectious diseases, including viral hepatitis and HIV/AIDS, across HHS 
and monitors progress toward achieving established goals; (2) Advises 
on issues related to blood and blood products; (3) Monitors the 
implementation of the National HIV/AIDS Strategy across HHS; (4) 
Identifies critical HIV/AIDS policy issues, including the inter-and 
intra-agency coordination need, and advises on how best to address/
resolve these issues; (5) Serves as HHS liaison with the Office of the 
National AIDS Policy Coordinator, Executive Office of the President; 
(6) Assists in the preparation of responses to inquiries regarding 
programs and policies intended to promote effective prevention and 
advancement of research for HIV/AIDS, viral hepatitis, and other 
infectious diseases of public health significance; (7) Provides liaison 
with other Federal organizations involved in addressing HIV/AIDS, viral 
hepatitis and/or other infectious diseases of public health 
significance; (8) Provides analytic and administrative support to the 
Advisory Committee on Blood Safety and Availability (ACBSA), the 
Presidential Advisory Council on HIV/AIDS (PACHA), cross-Departmental, 
coordinating groups, and other subsidiary or independent task forces, 
work groups, or subgroups; (9) Provides guidance on the cooperative 
dissemination and exchange of scientific, prevention, educational 
information, and clinical guidelines between public health interest 
groups, health professional, and private sector organizations; (10) 
Guides, supports, and promotes methods of dissemination and exchange of 
information to and among the public; (11) Reviews and makes 
recommendations on OPDIVs budget requests related to departmental 
research, prevention, services, training, information, and 
infrastructure priorities as incorporated in planning documents or 
budget proposals.
    II. Delegations of Authority. Pending further re-delegation, 
directives or orders made by the Secretary, the Assistant Secretary for 
Health, or the Deputy Assistant Secretary for Health, Infectious 
Diseases, all delegations and re-delegations of authority made to 
officials and employees of the affected organizational component will 
continue in them pending further re-delegations, provided they are 
consistent with this reorganization.

    Dated: March 6, 2012.
E.J. Holland, Jr.,
Assistant Secretary for Administration.
[FR Doc. 2012-6466 Filed 3-15-12; 8:45 am]
BILLING CODE 4150-28-P